A Multi-center, Randomized, Open-label, Active Comparator-controlled, Phase 4 Clinical Trial To Evaluate the Efficacy and Safety of Telmisartan Compared With Losartan in Patients With Diabetic Nephropathy and Hypertension
Latest Information Update: 31 May 2024
At a glance
- Drugs Telmisartan (Primary) ; Losartan
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Chong Kun Dang
Most Recent Events
- 31 May 2024 New trial record